Home › Funds › Diametric Capital, LP › CABA
Diametric Capital, LP position in CABA
CABALETTA BIO INC · Health Care
Diametric Capital, LP reported holding 1,872,614 shares of CABA (CABALETTA BIO INC) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 0.32% of its reported portfolio and ranking #46 among its reported holdings. Diametric Capital, LP has disclosed CABA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Diametric Capital, LP's CABA position evolved
Diametric Capital, LP first disclosed a stake in CABA in Q1 2026 at 262,831 shares (US$707K). The position peaked in Q3 2026 at 1,872,614 shares, worth US$3.6M. Across 3 filings, Diametric Capital, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,872,614 shares valued at US$3.6M — an increase of 1,737,016 shares quarter over quarter.. Notable position changes include a 48% trim in Q2 2026 (shares fell 38% over the following quarter), a 1281% increase in Q3 2026 (shares fell 42% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 262.83K | $707.01K | New |
| Q2 2026 | 135.60K | $421.71K | Reduce |
| Q3 2026 | 1.87M | $3.60M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CABA and 13F data
CABA (CABALETTA BIO INC) is a Health Care company. 29 other funds we track also report a position in CABA — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$40.7M), Opaleye Management Inc. (US$12.0M), Cormorant Asset Management, LP (US$8.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CABA
- Bain Capital Life Sciences Investors, LLC 21.21M sh · $40.72M · Q3 2026
- Opaleye Management Inc. 3.86M sh · $12.02M · Q2 2026
- Cormorant Asset Management, LP 4.50M sh · $8.64M · Q3 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 2.50M sh · $4.80M · Q3 2026
- Propel Bio Management, LLC 2.05M sh · $3.93M · Q3 2026
More on Diametric Capital, LP
FAQ
How long has Diametric Capital, LP held CABA?
Diametric Capital, LP has disclosed CABA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Diametric Capital, LP's current position in CABA?
As of Q3 2026, Diametric Capital, LP holds 1.87M shares of CABA (CABALETTA BIO INC), valued at $3.60M, representing 0.32% of its reported portfolio and ranking #46.
Has Diametric Capital, LP been buying or selling CABA?
In the latest 13F filing (Q3 2026), Diametric Capital, LP increased its position in CABA. The position peaked in Q3 2026 at 1.87M shares.
Which other funds hold CABA?
Other major institutional holders of CABA include Bain Capital Life Sciences Investors, LLC, Opaleye Management Inc., Cormorant Asset Management, LP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.